[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100337163":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":23,"responsibleParty":41,"collaborators":7,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":7,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":7,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":7,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"IRCCS San Raffaele","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","Endoscopic fundoplication","Endoscopic fundoplication is a less invasive alternative to the traditional surgical fundoplication.\n\nThe MUSE device is similar to an endoscope, so the whole procedure can be done by a single operator. The device is composed of a shaft with a distal rigid part which is placed in the esophagus 3 cm proximal to the esophago-gastric junction containing a cartridge holding five B-shaped titanium surgical Staples and a tip which is retroflexed and contains an ultrasonic transducer which defines the correct tissue thickness for stapling the fundus against the esophagus. The device must be extracted to be reloaded with 5 more staples at a time for creation of a 180° anterior fundoplication.",[14],{"name":15,"affiliation":16,"role":17},"Pier Alberto Testoni, Professor","San Raffaele Scientific Institute","PRINCIPAL_INVESTIGATOR",[19],{"name":15,"role":20,"phone":21,"phoneExt":7,"email":22},"CONTACT","+390226432756","testoni.pieralberto@hsr.it",[24],{"facility":25,"status":26,"city":27,"state":7,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Pier Alberto Testoni","RECRUITING","Milan","20132","Italy","IT",{"type":32,"coordinates":33},"Point",[34,35],9.18951,45.46427,{"lat":35,"lon":34},[38],{"name":39,"role":20,"phone":40,"phoneExt":7,"email":7},"Pier Alberto Testoni, MD","00390226432756",{"type":17,"investigatorFullName":25,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Professor","100337163","endoscopic-fundoplication-with-muse-system-100337163",false,"NCT03669874","Endoscopic Fundoplication With MUSE System","Clinical Application of MUSE System for Ultrasound-guided Endoscopic Fundoplication for Gastro-esophageal Reflux Disease Patients","Inclusion Criteria:\n\n* Chronic (\\> 6 months) GERD-related esophageal or extra-esophageal symptoms\n* Endoscopic or pH-impedance evidence of GERD (esophagitis, Barrett's esophagus, NERD, hypersensitive esophagus)\n* Indication to surgical fundoplication\n* Patients available for a long-term follow-up\n\nExclusion Criteria:\n\n* Hiatal hernia ≥ 3 cm\n* Major esophageal motility disorder\n* Esophageal stenosis\n* Malignant neoplasia (except minor superficial skin neoplasm)\n* Portal hypertension, bleeding disorders so to controindicate surgery, esophageal varices, stenosis or diverticula\n* Previous cardiac, thoracic or upper GI surgery\n* BMI \\>40\n* Pregnancy or breast feeding","ALL","18 Years","70 Years",{"count":54,"type":55},80,"ESTIMATED","OBSERVATIONAL","This is a spontaneous, prospective, monocentric, observational, cohort study, with the aim of evaluating the effect of ultrasound-guided endoscopic fundoplication using the Medigus Ultrasonic Surgical Endostapler (MUSESystem; MediGus, Ltd. Israel) in patients with esophageal or extra-esophageal gastro-oesophageal reflux disease (GERD)-related symptoms. The end of the study will be at the end of the 6-year follow-up of the last patient enrolled. The study proposes the following objectives:\n\n* Primary objective: to evaluate the efficacy of endoscopic fundoplication with MUSE for the treatment of GERD, through clinical experience, in terms of:\n\n  * effect on GERD-Health Related Quality of Life (HRQL) and Reflux Symptom Index (RSI) questionnaire scores\n  * effect on the use and dosage of proton pump inhibitors (PPI)\n  * feasibility and safety of the endoluminal fundoplication procedure\n* Secondary objective: to characterize the treated patient population (demographic and objective data) and to identify the successful predictors of the procedure.\n\nThe study design includes the following phases:\n\n\\*Preliminary patient evaluation and verification of inclusion criteria through: Upper GI endoscopy Esophageal high-resolution manometry 24-hours esophageal pH-impedance OFF PPI PPI use GERD-HRQL and RSI questionnaires scores OFF PPI\n\n* 6-month follow-up: Upper GI endoscopy Esophageal high-resolution manometry 24-hours esophageal pH-impedance OFF PPI PPI use GERD-HRQL and RSI questionnaires scores OFF PPI\n* 12-months follow-up: Upper GI endoscopy 24-hours esophageal pH-impedance OFF PPI PPI use GERD-HRQL and RSI questionnaires scores OFF PPI\n* Yearly clinical follow-up (up to 6 years):\n\nPPI use GERD-HRQL and RSI questionnaires scores OFF PPI",[59,60],"Gastro-esophageal Reflux","Endoscopic Fundoplication","2020-12-10",{"date":63,"type":64},"2020-12-11","ACTUAL",{"date":66,"type":64},"2015-09-16",{"date":68,"type":55},"2026-09",{"name":5,"class":6},1]